This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a chiral center and a tert-butylphenyl group, makes it valuable in the development of enantiomerically pure drugs, particularly those targeting central nervous system disorders. It is often employed in the production of selective serotonin reuptake inhibitors (SSRIs) and other neuroactive compounds. Additionally, its hydrochloride salt form enhances stability and solubility, making it suitable for formulation processes. Researchers also explore its potential in creating novel therapeutic agents due to its unique stereochemical properties.